Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kunal N. Jobanputra"'
Autor:
Kunal N Jobanputra
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 3, Pp 478-479 (2023)
Externí odkaz:
https://doaj.org/article/3cc2a99e3e134074b42025e1056d59d2
Autor:
Manju Sengar, Badira Cheriyalinkal Parambil, Jyoti Bajpai, Bhausaheb Bagal, Vanita Noronha, Shripad Banavali, Chetan Dhamne, Amit Kumar, Prabhat Bhargava, Amit Joshi, Vikas Ostwal, Kumar Prabhash, Sushmita Rath, Sudeep Gupta, Gaurav Narula, Hasmukh Jain, Minit Shah, Lingaraj Nayak, Tushar Vora, Kunal N. Jobanputra, Sachin Punatar, Nirmalya Roy Moulik, Sujay Srinivas, Nandini Menon, Vijay Patil, Girish Chinnaswamy, Jaya Ghosh, Avinash Bonda, Jayashree Thorat, Anant Ramaswamy, Navin Khattry, Seema Gulia, Anant Gokarn, Maya Prasad, Akhil Kapoor
Publikováno v:
Cancer Medicine
Background There is limited data on outcomes in cancer patients with coronavirus disease 2019 (COVID‐19) from lower middle‐income countries (LMICs). Patients and Methods This was an observational study, conducted between 12 April and 10 June 2020
Publikováno v:
Blood. 138:2515-2515
Introduction Diffuse large B-cell lymphoma (DLBCL) commonly affects the elderly population and the treatment is often challenging because of the close interplay between age, comorbidities, frailty as well as cognitive and psychosocial factors. Anthra
Autor:
Vanita Noronha, Kumar Prabhash, Shreya Gattani, Nandini Menon, Kunal N. Jobanputra, Vijay Patil, George Abraham
Publikováno v:
Cancer Research, Statistics, and Treatment. 4:270
Background: Older patients with cancer are underrepresented in most immunotherapy trials. Therefore, there is an urgent and unmet need for real-world data on the efficacy and safety of immune checkpoint inhibitors (ICIs) in older patients with cancer